landing med was founded in wuhan, china, in 2000 by dr. xiaorong sun with the aim of developing and applying leading-edge early cancer diagnostic technologies to decrease cancer-related mortalities. dr. sun and her team has developed automated pre-cancer detection technologies and an innovative population-based cervical cancer screening model that has screened more than 4 million women in 4 years. landing med’s solutions and model are effective for health organizations that lack experienced pathologists and/or process high sample volumes. by automatically detecting suspicious cells, landing med’s technology reduces pathologists’ work burden and enables them to focus on making the diagnosis. globally, landing med is present in china, malaysia, indonesia and pakistan.
|
|